The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Jul 2014
Randomized Controlled Trial Multicenter StudyGefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
Evidence is scarce for the effectiveness of therapies for oesophageal cancer progressing after chemotherapy, and no randomised trials have been reported. We aimed to compare gefitinib with placebo in previously treated advanced oesophageal cancer. ⋯ Cancer Research UK.
-
The lancet oncology · Jul 2014
Randomized Controlled Trial Multicenter StudyGemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
We aimed to assess the efficacy and safety of sequential or simultaneous telomerase vaccination (GV1001) in combination with chemotherapy in patients with locally advanced or metastatic pancreatic cancer. ⋯ Cancer Research UK and KAEL-GemVax.